Sugar molecules could be the key to a new weapon against drug-resistant bacteria. A groundbreaking study has uncovered a unique vulnerability in these bacteria, offering a promising approach to developing life-saving immunotherapies. The research focuses on a sugar molecule called pseudaminic acid, which is exclusively produced by bacteria and plays a crucial role in their survival. While it resembles sugars found on human cells, pseudaminic acid is a highly differentiated target for immunotherapy. The team's innovative approach involved chemically synthesizing the bacterial sugar and sugar-decorated peptides from scratch, allowing them to determine the molecule's exact three-dimensional structure and its presentation on bacterial surfaces. This led to the creation of a 'pan-specific' antibody capable of recognizing the sugar across various bacterial species and strains. In mouse infection models, this antibody successfully eliminated multidrug-resistant Acinetobacter baumannii, a notorious cause of hospital-acquired infections. Professor Goddard-Borger emphasizes the critical threat posed by multidrug-resistant Acinetobacter baumannii in modern healthcare facilities, highlighting the urgency of finding new treatments. The study, published in Nature Chemical Biology, showcases the power of combining chemical synthesis with biochemistry, immunology, microbiology, and infection biology. By precisely building these bacterial sugars in the lab, the researchers were able to understand their shape at the molecular level and develop highly specific antibodies. This breakthrough opens up new possibilities for treating devastating drug-resistant bacterial infections. The antibodies also provide valuable insights into how bacteria cause disease, enabling better diagnostics and therapies. The team's long-term goal is to translate these findings into clinic-ready antibody therapies targeting multidrug-resistant A. baumannii, which could significantly impact the global fight against antimicrobial resistance. Additionally, the study's implications extend beyond medicine, as the Australian Research Council Centre of Excellence for Advanced Peptide and Protein Engineering aims to accelerate the translation of such discoveries into applications in biotechnology, agriculture, and conservation.
